Skip to content
Open access

Short- and long-term impact of SARS-CoV-2 on clinical characteristics of Graves’ disease patients: a retrospective cohort study

Sep 2026 · Endocrine Connections · Vol 15 · 0 citations · 27 references
Medicine

Abstract

Background The aim of this study was to comprehensively evaluate the effects of SARS-CoV-2 infection on treated Graves’ disease (GD) patients. Methods This single-center retrospective cohort study included 220 patients with GD receiving stable antithyroid drug treatment. Among 179 questionnaire respondents, 107 had confirmed SARS-CoV-2 infection and 72 were uninfected. Paired thyroid function analyses were performed in 65 infected patients, and long COVID was assessed in 72 participants. Results In the cohort, 107 patients (77.6% female; 78.5% aged <60 years) were infected with SARS-CoV-2. COVID-19 vaccination was less frequent among infected than among uninfected participants (70.1 vs 84.7%, P = 0.025). At 12 weeks postinfection, TT3 increased from 1.76 to 1.97 nmol/L (P = 0.032), whereas TSH, FT3, FT4, TT4, and TRAb remained unchanged. Total cholesterol and HDL-C decreased after infection. TT3 changes differed by vaccination status (P for interaction = 0.019), although vaccination was not associated with biochemical thyroid function deterioration (OR: 0.88, 95% CI: 0.25–3.12). Among 72 participants who completed long COVID assessment, 37 (51.4%) met the operational definition; increased hair loss was the most common symptom. Smoking was associated with higher odds of long COVID (OR: 5.37, 95% CI: 1.05–27.36). Conclusion SARS-CoV-2 infection in treated GD patients was associated with modest short-term thyroid and metabolic changes, while most thyroid indices remained stable. These exploratory findings highlight the need for further prospective studies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.